J Knee Surg 2017; 30(04): 309-313
DOI: 10.1055/s-0036-1584559
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Infections after Anterior Cruciate Ligament Reconstruction: Which Antibiotic after Arthroscopic Debridement?

Daniel Pérez-Prieto
1   Department of Orthopaedic Surgery, Hospital del Mar—Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
,
Andrej Trampuz
2   Center for Septic Surgery, Charité – University Medicine, Berlin, Germany
,
Raúl Torres-Claramunt
1   Department of Orthopaedic Surgery, Hospital del Mar—Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
,
María Eugenia Portillo
3   Department of Clinical Microbiology, Complejo Hospitalario de Navarra, Pamplona, Spain
,
Lluís Puig-Verdié
1   Department of Orthopaedic Surgery, Hospital del Mar—Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
,
Joan C. Monllau
1   Department of Orthopaedic Surgery, Hospital del Mar—Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
› Author Affiliations
Further Information

Publication History

07 February 2016

09 May 2016

Publication Date:
01 July 2016 (online)

Abstract

Arthroscopic debridement has proven to be the optimal surgical treatment for infections of the anterior cruciate ligament reconstruction (ACLR). Nevertheless, there are no reported data for the best antibiotic treatment option and its duration. The purpose of this article is to assess the usefulness of oral levofloxacin and rifampicin for the treatment of acute infections of an ACLR. This is a retrospective observational cohort study of patients operated on for ACLR over 4 years. A diagnosis of septic arthritis was based on patients' anamnesis and physical examination, laboratory parameters, and cultures of synovial fluid and/or joint tissue. Arthroscopic lavage was performed as soon as possible and tissue samples were taken. At a minimum 2-year follow-up, the infection was considered cured with a normal C-reactive protein (CRP) level and a correctly functioning and pain-free knee. Of the 810 patients, 15 (1.8%) were diagnosed as having an infection. Among the 13 staphylococcal cases (86.6%), 10 were susceptible to both quinolones and rifampicin (76.9% of the staphylococcal infections). There were two staphylococci that were rifampicin resistant. In the remaining one case, the coagulase-negative staphylococcus (CNS) was resistant to quinolones. One CNS infection was treated with linezolid and rifampicin and was the only case that needed graft removal due to treatment failure. Antibiotic treatment lasted an average of 6 weeks and oral treatment started at a mean of 5 days (range, 4–7). In the remaining 12 patients, CRP levels returned to normal at a mean of 3 weeks with good knee function and no local symptoms. Staphylococci (especially CNS) are responsible for almost 90% of acute ACLR infections in the current series. For the first time, the combination of levofloxacin and rifampicin is being proposed as a treatment in cases of an acute staphylococcal infection of an ACLR. An early switch to oral antibiotic treatment (as soon as the cultures are available) with both levofloxacin and rifampicin for a total (empiric and directed) period of 6 weeks should be considered as treatment of choice in acute staphylococcal infections of the ACLR with a retained graft. The level of evidence is IV (case series).

 
  • References

  • 1 Boström Windhamre H, Mikkelsen C, Forssblad M, Willberg L. Postoperative septic arthritis after anterior cruciate ligament reconstruction: does it affect the outcome? A retrospective controlled study. Arthroscopy 2014; 30 (9) 1100-1109
  • 2 Cadet ER, Makhni EC, Mehran N, Schulz BM. Management of septic arthritis following anterior cruciate ligament reconstruction: a review of current practices and recommendations. J Am Acad Orthop Surg 2013; 21 (11) 647-656
  • 3 Lind M, Menhert F, Pedersen AB. The first results from the Danish ACL reconstruction registry: epidemiologic and 2 year follow-up results from 5,818 knee ligament reconstructions. Knee Surg Sports Traumatol Arthrosc 2009; 17 (2) 117-124
  • 4 Mouzopoulos G, Fotopoulos VC, Tzurbakis M. Septic knee arthritis following ACL reconstruction: a systematic review. Knee Surg Sports Traumatol Arthrosc 2009; 17 (9) 1033-1042
  • 5 Saper M, Stephenson K, Heisey M. Arthroscopic irrigation and debridement in the treatment of septic arthritis after anterior cruciate ligament reconstruction. Arthroscopy 2014; 30 (6) 747-754
  • 6 Abdel-Aziz A, Radwan YA, Rizk A. Multiple arthroscopic debridement and graft retention in septic knee arthritis after ACL reconstruction: a prospective case-control study. Int Orthop 2014; 38 (1) 73-82
  • 7 Torres-Claramunt R, Pelfort X, Erquicia J , et al. Knee joint infection after ACL reconstruction: prevalence, management and functional outcomes. Knee Surg Sports Traumatol Arthrosc 2013; 21 (12) 2844-2849
  • 8 Sonnery-Cottet B, Thaunat M, Archbold P, Issartel B, Cadet ER. Management of septic arthritis following anterior cruciate ligament reconstruction: a review of current practices and recommendations. J Am Acad Orthop Surg 2014; 22 (5) 271-273
  • 9 Wang C, Lee YH, Siebold R. Recommendations for the management of septic arthritis after ACL reconstruction. Knee Surg Sports Traumatol Arthrosc 2014; 22 (9) 2136-2144
  • 10 Kim YM, Joo YB. Clinical presentation of Staphylococcus epidermidis septic arthritis following anterior cruciate ligament reconstruction. Knee Surg Relat Res 2012; 24 (1) 46-51
  • 11 Maletis GB, Inacio MC, Reynolds S, Desmond JL, Maletis MM, Funahashi TT. Incidence of postoperative anterior cruciate ligament reconstruction infections: graft choice makes a difference. Am J Sports Med 2013; 41 (8) 1780-1785
  • 12 Sonnery-Cottet B, Archbold P, Zayni R , et al. Prevalence of septic arthritis after anterior cruciate ligament reconstruction among professional athletes. Am J Sports Med 2011; 39 (11) 2371-2376
  • 13 Trampuz A, Zimmerli W. Antimicrobial agents in orthopaedic surgery: prophylaxis and treatment. Drugs 2006; 66 (8) 1089-1105
  • 14 Portillo ME, Salvadó M, Trampuz A , et al. Improved diagnosis of orthopedic implant-associated infection by inoculation of sonication fluid into blood culture bottles. J Clin Microbiol 2015; 53 (5) 1622-1627
  • 15 Judd D, Bottoni C, Kim D, Burke M, Hooker S. Infections following arthroscopic anterior cruciate ligament reconstruction. Arthroscopy 2006; 22 (4) 375-384
  • 16 Pérez-Prieto D, Torres-Claramunt R, Gelber PE, Shehata TM, Pelfort X, Monllau JC. Autograft soaking in vancomycin reduces the risk of infection after anterior cruciate ligament reconstruction (e-pub ahead of print). Knee Surg Sports Traumatol Arthrosc 2014; DOI: 10.1007/s00167-014-3438-y.
  • 17 Vertullo CJ, Quick M, Jones A, Grayson JE. A surgical technique using presoaked vancomycin hamstring grafts to decrease the risk of infection after anterior cruciate ligament reconstruction. Arthroscopy 2012; 28 (3) 337-342
  • 18 Trampuz A, Perka C, Borens O. Prosthetic joint infection: new developments in diagnosis and treatment [in German]. Dtsch Med Wochenschr 2013; 138 (31–32): 1571-1573
  • 19 Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004; 351 (16) 1645-1654
  • 20 Tande AJ, Patel R. Prosthetic joint infection. Clin Microbiol Rev 2014; 27 (2) 302-345
  • 21 Schrenzel J, Harbarth S, Schockmel G , et al; Swiss Staphylococcal Study Group. A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection. Clin Infect Dis 2004; 39 (9) 1285-1292
  • 22 John AK, Baldoni D, Haschke M , et al. Efficacy of daptomycin in implant-associated infection due to methicillin-resistant Staphylococcus aureus: importance of combination with rifampin. Antimicrob Agents Chemother 2009; 53 (7) 2719-2724
  • 23 Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE ; Foreign-Body Infection (FBI) Study Group. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. JAMA 1998; 279 (19) 1537-1541
  • 24 Baldoni D, Haschke M, Rajacic Z, Zimmerli W, Trampuz A. Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection. Antimicrob Agents Chemother 2009; 53 (3) 1142-1148